Features of cytokine balance in patients with precancerous gastric lesions depending on the changes in the structure of the thyroid gland

Authors

  • L.M. Mosiychuk SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine
  • I.V. Kushnirenko SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine
  • O.M. Tatarchuk SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine
  • I.S. Konenko SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine
  • O.P. Petishko SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine

DOI:

https://doi.org/10.22141/2308-2097.54.3.2020.211732

Keywords:

atrophy, metaplasia, dysplasia, thyroid gland, cytokines, vascular endothelial growth factor

Abstract

Background. The study of the cytokine balance is important due to searching the general links of the pathogenesis of comorbidity in precancerous gastric lesions and thyroid diseases. The purpose was to determine the peculiarities of the cytokine balance in terms of the level of vascular endothelial growth factor (VEGF), tumor necrotizing factor (TNF) α, interleukins (IL) 8 and IL-18 in patients with precancerous gastric lesions depending on the changes in the structure of the thyroid gland. Materials and methods. Forty-five patients with precancerous gastric lesions were examined. Inclusion criteria were as follows: intestinal metaplasia in the body and/or antrum, atrophy in the body of the stomach. According to the results of an ultrasound examination of the thyroid gland, patients are divided into the groups: group I — 19 patients with nodular changes, group II — 18 patients with diffuse changes, and group III — 8 patients without changes. The control group included 10 healthy individuals. The level of IL-8, IL-18, TNF-α, VEGF was determined in the blood serum by the enzyme immunoassay using reagent kits of the Vector-BEST company, Novosibirsk, Russia. Results. 82.2 % patients with precancerous gastric lesions developed the changes in the structure of the thyroid gland (n = 37), 42.2 % (n = 19) had nodular changes in. The concentration of IL-8 in patients of group I was higher compared with group II, III and control group by 2.0 (p < 0.05), 2.7 (p < 0.05), and 3.1 times (p < 0.05), respectively. The concentration of TNF-α in group I was significantly higher compared with the II, III and control groups by 2.3 (p < 0.05), 3.5 (p < 0.05), and 1.4 times (p < 0.05), respectively. A correlation between the level of TNF-α and IL-8 (r = 0.487, p = 0.001) was established. The level of VEGF was significantly increased in group I by 4.3 times (p < 0.05) and in group II by 2.5 times (p < 0.05) compared with the control. Also, in patients of group I, its content was significantly higher — 1.7 and 2.9 times compared with groups II and III (p < 0.01 and p < 0.001, taking into account the Bonferroni correction, respectively). According to the results of the Kruskal-Wallis test, the difference in VEGF level between groups was 0.002. VEGF expression correlates with the level of TNF-α (r = 0.442, p = 0.004) and with the level of IL-8 (r = 0.319, p = 0.042). A direct association was found between the level of VEGF and the simultaneous detection of intestinal metaplasia in the body and antrum (r = 0.443, p = 0.008), intestinal metaplasia in the body, antrum and angle of the stomach (r = 0.404, p = 0.024), intestinal metaplasia in the stomach body (r = 0.340, p = 0.039). Conclusions. 82.2 % patients with precancerous gastric lesions were found to have the changes in the structure of the thyroid gland, which is accompanied by an increase in the VEFG level, which directly correlates with the intestinal metaplasia in the stomach. 42.2 % of patients showed nodular changes in the thyroid gland, which is also accompanied by an increase in the levels of IL-8 and TNF-α. Such data indicate the importance of further studying of the role of cytokines in the development of comorbidity in precancerous gastric lesions.

Downloads

Download data is not yet available.

References

Brown AR, Simmen RC, Simmen FA. The role of thyroid hormone signaling in the prevention of digestive system cancers. Int J Mol Sci. 2013;14(8):16240-16257. doi: 10.3390/ijms140816240.

Kandemir EG, Yonem A, Narin Y. Gastric carcinoma and thyroid status. J Int Med Res. 2005;33(2):222-227. doi:10.1177/147323000503300210.

Abnet CC, Fan JH, Kamangar F, et al. Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort. Int J Cancer. 2006;119(6):1508-1510. doi:10.1002/ijc.21993.

Shen Z, Qin Y, Liu Y, et al. Helicobacter pylori infection is associated with the presence of thyroid nodules in the euthyroid population. PLoS One. 2013;8(11):e80042. doi:10.1371/journal.pone.0080042.

Behrouzian R, Aghdami N. Urinary iodine/creatinine ratio in patients with stomach cancer in Urmia, Islamic Republic of Iran. East Mediterr Health J. 2004;10(6):921-924.

Gołkowski F, Szybiński Z, Rachtan J, et al. Iodine prophylaxis--the protective factor against stomach cancer in iodine deficient areas. Eur J Nutr. 2007;46(5):251-256. doi:10.1007/s00394-007-0657-8.

Maykova TV, Kushnirenko IV, Zalyubovska OI, Pushkina MI. Poednana patologіja gastroduodenal'noi zoni і shhitovidnoї zalozi: mehanіzmi formuvannja, pіdhodi do bagatofaktornoї dіagnostiki і patogenetichnogo lіkuvannja: posіbnik dlja lіkarіv [Combined pathology of the gastroduodenal zone and thyroid gland: mechanisms of formation, approaches to multifactorial diagnosis and pathogenetic treatment: manual for doctors]. Kyiv: KVIZ; 2012. 128p. (in Ukrainian).

Portela-Gomes GM, Albuquerque JP, Ferra MA. Serotonin and gastrin cells in rat gastrointestinal tract after thyroparathyroidectomy and induced hyperthyroidism. Dig Dis Sci. 2000;45(4):730-735. doi:10.1023/a:1005495710741.

Rafsanjani FN, Z Asl S, Naseri MK, Vahedian J. Effects of thyroid hormones on basal and stimulated gastric acid secretion due to histamine, carbachol and pentagastrin in rats. Saudi Med J. 2003;24(4):341-346.

Lee JH, Kwon OD, Ahn SH, et al. Reduction of gastrointestinal motility by unilateral thyroparathyroidectomy plus subdiaphragmatic vagotomy in rats. World J Gastroenterol. 2012;18(33):4570-4577. doi:10.3748/wjg.v18.i33.4570.

Kahraman H, Kaya N, Demirçali A, Bernay I, Tanyeri F. Gastric emptying time in patients with primary hypothyroidism. Eur J Gastroenterol Hepatol. 1997;9(9):901-904. doi:10.1097/00042737-199709000-00014.

Santi A, Duarte MM, Moresco RN, et al. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin Chem Lab Med. 2010;48(11):1635-1639. doi:10.1515/CCLM.2010.309.

Stenken JA, Poschenrieder AJ. Bioanalytical chemistry of cytokines--a review. Anal Chim Acta. 2015;853:95-115. doi:10.1016/j.aca.2014.10.009.

Simbircev АS, Totoljan AA. Cytokines in laboratory diagnostics. Infectious diseases: news, opinions, education. 2015;2:82-98. (in Russian).

Apte RS, Chen DS, Ferrara N. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019;176(6):1248-1264. doi:10.1016/j.cell.2019.01.021.

Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581-611. doi:10.1210/er.2003-0027.

Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69 Suppl 3:4-10. doi:10.1159/000088478.

Matsumoto K, Ema M. Roles of VEGF-A signalling in development, regeneration, and tumours. J Biochem. 2014;156(1):1-10. doi:10.1093/jb/mvu031.

Costache MI, Ioana M, Iordache S, Ene D, Costache CA, Săftoiu A. VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature. Rom J Intern Med. 2015;53(3):199-208. doi:10.1515/rjim-2015-0027.

Siveen KS, Prabhu K, Krishnankutty R, et al. Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges. Curr Vasc Pharmacol. 2017;15(4):339-351. doi:10.2174/1570161115666170105124038.

Melincovici CS, Boşca AB, Şuşman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455-467.

Moehler M, Gepfner-Tuma I, Maderer A, et al. Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program. BMC Cancer. 2016;16(1):699. doi:10.1186/s12885-016-2736-9.

Ferrara N, Hillan KJ, Novotny W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun. 2005;333(2):328-335. doi:10.1016/j.bbrc.2005.05.132.

Ferrari SM, Centanni M, Virili C, et al. Sunitinib in the Treatment of Thyroid Cancer. Curr Med Chem. 2019;26(6):963-972. doi:10.2174/0929867324666171006165942.

Zhang X, Zhou Y, Wu X, et al. Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study. Eur J Surg Oncol. 2019;45(3):318-323. doi:10.1016/j.ejso.2018.08.001.

Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov. 2016;15(6):385-403. doi:10.1038/nrd.2015.17.

Frezzetti D, Gallo M, Maiello MR, et al. VEGF as a potential target in lung cancer. Expert Opin Ther Targets. 2017;21(10):959-966. doi:10.1080/14728222.2017.1371137.

Wang XY, Wang LL, Zheng X, Meng LN, Lyu B, Jin HF. Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats. World J Gastrointest Oncol. 2016;8(3):305-313. doi:10.4251/wjgo.v8.i3.305.

Raica M, Mogoantă L, Cîmpean AM, et al. Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma. Rom J Morphol Embryol. 2008;49(1):37-42.

Liu D, He Q, Liu C. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia. J Gastroenterol Hepatol. 2010;25(4):795-799. doi:10.1111/j.1440-1746.2009.06168.x.

Kim JY, Jeon TJ, Bae BN, et al. The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma. APMIS. 2013;121(2):95-104. doi:10.1111/j.1600-0463.2012.02942.x.

Siregar GA, Halim S, Sitepu VR. Serum TNF-a, IL-8, VEGF levels in Helicobacter pylori infection and their association with degree of gastritis. Acta Med Indones. 2015;47(2):120-126.

Siregar G, Sari D, Sungkar T. Serum VEGF Levels in Helicobacter pylori Infection and Correlation with Helicobacter pylori cagA and vacA Genes. Open Access Maced J Med Sci. 2017;5(2):137-141. Published 2017 Mar 19. doi:10.3889/oamjms.2017.031.

Aksoy EK, Akpınar MY, Doğan Ö, et al. Clinical Significance of Serum Vascular Endothelial Growth Factor, Pigment Epithelium-Derived Factor, Tumor Necrosis Factor Alpha, and Progranulin Levels in Patients with Gastric Cancer and Gastric Precancerous Lesions. J Gastrointest Cancer. 2019;50(3):537-542. doi:10.1007/s12029-019-00251-8.

Klein M, Catargi B. VEGF in physiological process and thyroid disease. Ann Endocrinol (Paris). 2007;68(6):438-448. doi:10.1016/j.ando.2007.09.004.

Su JJ, Hui LZ, Xi CJ, Su GQ. Correlation analysis of ultrasonic characteristics, pathological type, and molecular markers of thyroid nodules. Genet Mol Res. 2015;14(1):9-20. doi:10.4238/2015.January.15.2.

Bilgici B, Ecemis GC, Tuncel OK, Bayrak IK, Kan EK, Atmaca A. VEGF and GM-CSF levels in nodular thyroid diseases. Endocrine. 2014;45(1):61-66. doi:10.1007/s12020-013-9945-7.

Haytaoglu G, Kuzu F, Arpaci D, et al. Correlation of vascular endothelial growth factor and vascular endothelial growth factor receptor-1 levels in serum and thyroid nodules with histopathological and radiological variables. J Lab Physicians. 2019;11(1):51-57. doi:10.4103/JLP.JLP_41_18.

Kilic I, Guldiken S, Sipahi T, et al. Investigation of VEGF and IL-8 Gene Polymorphisms in Patients with Differentiated Thyroid Cancer. Clin Lab. 2016;62(12):2319-2325. doi:10.7754/Clin.Lab.2016.160403.

Coperchini F, Pignatti P, Carbone A, et al. TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer. Tumour Biol. 2016;37(4):5569-5575. doi:10.1007/s13277-015-4418-7.

Li ZW, Wu Y, Sun Y, et al. Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia. World J Gastroenterol. 2010;16(14):1788-1794. doi:10.3748/wjg.v16.i14.1788.

Wang YM, Li ZX, Tang FB, et al. Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population. Tumour Biol. 2016;37(2):2233-2242. doi:10.1007/s13277-015-4022-x.

Published

2021-09-06

How to Cite

Mosiychuk, L., Kushnirenko, I., Tatarchuk, O., Konenko, I., & Petishko, O. (2021). Features of cytokine balance in patients with precancerous gastric lesions depending on the changes in the structure of the thyroid gland. GASTROENTEROLOGY, 54(3), 127–134. https://doi.org/10.22141/2308-2097.54.3.2020.211732

Issue

Section

Original Researches

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>